Health Canada has authorized the Dexcom G7 15 Day Continuous Glucose Monitoring System for adults with diabetes.
At 12 months, adults with insulin-treated diabetes had significant improvements in HbA1c and hospitalizations.
Glucotrack (Nasdaq:GCTK) announced that it completed a strategic business combination with Lōkahi Therapeutics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results